1. Merck Collaborates with Dragonfly to Develop and Commercialize Novel Therapies Utilizing TriNKET Platform Published: Mar 19, 2020 | Tags: Merck, Collaborates, Dragonfly, Develop, Commercialize, Novel Therapies, Utilizing, TriNKET Platform 2. […]readmore
Tags : Moleculin
Shots: Moleculin will provide its lead candidate, WP1122, and related inhibitors along with technical support while UTMB will investigate candidates against multiple viruses including COVID-19, in connection with UTMB’s CBEID […]readmore
Shots: Moleculin collaborated with Emory University to conduct P-I trial for WP1066 to treat recurrent or refractory malignant brain tumors in pediatric patients The trial will be conducted at Aflac […]readmore
Shots: The P-I trial is assessing WP1066 in 15 patients with relapsed brain tumor for 6 to 8mos, testing its safety and tolerability in patients at MD Anderson Cancer Centre […]readmore